MT. Cook Pharma, Inc.
Records under this name other than patents MT. Cook Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,642,599 | Method of Treating Parkinson's Disease with Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity Formerly held Lapsed on the fee record Ended Feb 4, 2026 · High confidence | Lapsed on the fee record | Ended Feb 4, 2026 | High confidence |
| US 6,924,288 | Enantiomerically pure opioid diarylmethylpiperzine and methods of using same Formerly held Term ended Term ended May 1, 2023 · From the USPTO record | Term ended | Term ended May 1, 2023 | From the USPTO record |
| US 7,189,725 | Enantiomerically pure opioid diarylmethylpiperazine as a cardioprotection agent Formerly held Term ended Term ended Oct 8, 2022 · From the USPTO record | Term ended | Term ended Oct 8, 2022 | From the USPTO record |
| US 7,683,168 | Compositions of novel opioid compounds and method of use thereof Formerly held Lapsed on the fee record Ended Mar 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 23, 2022 | From the USPTO record |
| US 8,575,169 | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds Formerly held Lapsed on the fee record Ended Nov 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2021 | From the USPTO record |
| US 8,476,280 | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists Formerly held Lapsed on the fee record Ended Jul 2, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2021 | From the USPTO record |
| US 7,314,880 | Cardioprotective delta opioid receptor agonists and methods of using same Formerly held Lapsed on the fee record Ended Jan 1, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jan 1, 2020 | From the USPTO record |
| US 6,630,515 | Urinary incontinence therapy Formerly held Term ended Term ended Aug 21, 2018 · From the USPTO record | Term ended | Term ended Aug 21, 2018 | From the USPTO record |
| US 7,030,124 | Method of treating depression with delta receptor agonist compounds Formerly held Lapsed on the fee record Ended Apr 18, 2018 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2018 | From the USPTO record |
| US 6,300,332 | Methods for reducing respiratory depression and attendant side effects of mu opioid compounds Formerly held Lapsed on the fee record Ended Oct 9, 2009 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2009 | From the USPTO record |